News

Filter

Current filters:

None

176 to 185 of 97859 results

Regulatory shakeup needed to fight antimicrobial resistance, says PwC report

Regulatory shakeup needed to fight antimicrobial resistance, says PwC report

11-02-2015

Greater flexibility and guidance in clinical trial design, along with quicker review times, are needed…

Antibiotics and Infectious diseasesPharmaceuticalPwCResearchSocial Issues

New survey studies cancer therapies and targets in Europe

New survey studies cancer therapies and targets in Europe

11-02-2015

A study looking at cancer treatments in France, Italy, Germany, Spain and the UK has been published by…

EuropeGermanyOncologyPharmaceuticalResearch

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

Médecins du Monde challenges Gilead’s Sovaldi patent in EU

11-02-2015

The high price of US biotech major Gilead Sciences’ blockbuster hepatitis C (HCV) drug Sovaldi (sofosbuvir)…

Anti-viralsEuropeGilead SciencesPharmaceuticalPricingSovaldi

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

US FDA fails to reveal concerns over clinical trial falsification

US FDA fails to reveal concerns over clinical trial falsification

11-02-2015

Some 22 clinical trials over 15 years have been affected by falsification, according to figures from…

Clinical researchPharmaceuticalPharmaceutical sciencesPharmacologyUSA

EMA explains its redaction rules, responding to Ombudsman questions

EMA explains its redaction rules, responding to Ombudsman questions

11-02-2015

The European Medicines Agency has published a detailed response to the European Ombudsman’s questions…

AbbVieEuropeHumiraPharmaceuticalRegulation

Seattle Genetics posts losses but beats analyst forecasts

Seattle Genetics posts losses but beats analyst forecasts

11-02-2015

Bothell, Washington, USA-headquartered oncology specialist Seattle Genetics managed to beat analyst estimates…

AdcetrisBiotechnologyFinancialOncologySeattle GeneticsUSA

Top-line Ph III results of Takeda’s oral ixazomib met primary endpoint

Top-line Ph III results of Takeda’s oral ixazomib met primary endpoint

10-02-2015

Japan’s largest drugmaker Takeda Pharmaceutical announced that the randomized, double-blind, placebo-controlled…

ixazomibOncologyPharmaceuticalResearchTakeda Pharmaceutical

Pfenex soars on Lucentis biosimilar deal with Hospira

Pfenex soars on Lucentis biosimilar deal with Hospira

10-02-2015

Shares of US clinical-stage biotech firm Pfenex leapt 28% to $8.85 in morning trading, after the company…

BiosimilarsBiotechnologyGenentechGlobalHospiraLicensingLucentisNovartisOphthalmicsPF582PfenexResearchRoche

176 to 185 of 97859 results

COMPANY SPOTLIGHT

Menarini

Back to top